Introducing Crowell & Moring’s Compliance “Check-Up” for Government Contractors
Client Alert | 1 min read | 03.06.18
The Government Contracts and Corporate Groups at Crowell & Moring LLP are pleased to announce our Compliance “Check-Up” for Government Contractors, focused on providing pre-sale advice to government contractors and private equity sponsors contemplating selling or fundraising in the current market. Our team of over 80 experienced government contracts and transactional professionals stands ready to assist clients by providing (at no cost) a “Check-Up” – a diagnostic review of key diligence questions, aimed at identifying common compliance issues that can drive down sales prices and/or increase borrowing costs. By identifying these issues early in the diligence process, sellers can avoid common traps that may negatively impact deal terms, complicate reps and warranties, and make post-merger integration more difficult and expensive. For more information on our Compliance “Check-Up” for Government Contractors, please click here.
Contacts
Insights
Client Alert | 4 min read | 12.04.25
District Court Grants Preliminary Injunction Against Seller of Gray Market Snack Food Products
On November 12, 2025, Judge King in the U.S. District Court for the Western District of Washington granted in part Haldiram India Ltd.’s (“Plaintiff” or “Haldiram”) motion for a preliminary injunction against Punjab Trading, Inc. (“Defendant” or “Punjab Trading”), a seller alleged to be importing and distributing gray market snack food products not authorized for sale in the United States. The court found that Haldiram was likely to succeed on the merits of its trademark infringement claim because the products at issue, which were intended for sale in India, were materially different from the versions intended for sale in the U.S., and for this reason were not genuine products when sold in the U.S. Although the court narrowed certain overbroad provisions in the requested order, it ultimately enjoined Punjab Trading from importing, selling, or assisting others in selling the non-genuine Haldiram products in the U.S. market.
Client Alert | 21 min read | 12.04.25
Highlights: CMS’s Proposed Rule for Medicare Part C & D (CY 2027 NPRM)
Client Alert | 11 min read | 12.01.25
